Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Scholar Rock Holding Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 5 insiders, $923.1K in total
- Insiders trading
- 5
- Net value
- −$923.1K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Scholar Rock Holding Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Woods Keith | Chief Operating Officer | 572,021 | Sep 25, 2026 | 4 |
| Hallal David | Chief Executive Officer | 1,602,382 | Sep 23, 2026 | 5 |
| Flier Jeffrey S. | Director | 27,856 | Jul 6, 2026 | 2 |
| Gilman Michael | Director | 59,511 | Jul 6, 2026 | 2 |
| Burow Kristina | Director | 114,657 | Jul 6, 2026 | 3 |
| Reed Joshua | Director | 19,518 | Jul 6, 2026 | 2 |
| Peng Katie | Director | 34,301 | Jul 6, 2026 | 3 |
| Akkaraju Srinivas | Director | 27,971 | Jun 8, 2026 | 3 |
| Brudnick Richard | Director | 21,896 | Jun 8, 2026 | 1 |
| Sinha Vikas | Chief Financial Officer | 619,856 | Apr 20, 2026 | 3 |
| Vaishnaw Akshay | President of R&D | 630,542 | Apr 20, 2026 | 3 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 98,445 | Feb 25, 2026 | 7 |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | 126,012 | Feb 19, 2026 | 3 |
| Ho Junlin | GENERAL COUNSEL | 241,545 | Feb 19, 2026 | 3 |
| Parlavecchio Caryn | CHRO | 169,087 | Feb 19, 2026 | 3 |
| Debbane Raymond | 10% Owner | 10,825,013 | Feb 6, 2026 | 1 |
| Siren, L.L.C. | 10% Owner | 10,825,013 | Feb 6, 2026 | 1 |
| Invus Global Management, LLC | 10% Owner | 10,825,013 | Feb 6, 2026 | 1 |
| Sacco Tracey | Chief Commercial Officer | 71,750 | Apr 29, 2025 | 0 |
| Moore Erin | Interim PFO and PAO | 82,609 | Mar 25, 2025 | 0 |
| Myles Edward H | COO & CFO | 111,345 | Mar 12, 2025 | 0 |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | 425,561 | Mar 12, 2025 | 0 |
| Invus Public Equities Advisors, LLC | 10% Owner | 9,250,005 | Dec 12, 2024 | 0 |
| Invus Public Equities, L.P. | 10% Owner | 9,250,005 | Dec 12, 2024 | 0 |
| Nashat Amir | Director | 38,639 | May 13, 2024 | 0 |
| Samsara BioCapital, L.P. | 10% Owner | 6,788,609Indirect | Oct 18, 2023 | 0 |
| Samsara BioCapital GP, LLC | 10% Owner | 6,788,609Indirect | Oct 18, 2023 | 0 |
| Artal Group S.A. | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Artal International S.C.A. | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Westend S.A. | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Stichting Administratiekantoor Westend | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Artal International Management S.A. | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Wittouck Amaury | 10% Owner | 11,259,438 | Oct 16, 2023 | 0 |
| Mahanthappa Nagesh K. | Interim CEO and President | 480,491 | Jun 21, 2022 | 0 |
| Carven Gregory John | Chief Scientific Officer | 128,208 | Jun 21, 2022 | 0 |
| Chyung Yung H. | Chief Medical Officer | 258,496 | Feb 15, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Vaishnaw AkshayPresident of R&D | SSale | −12.2K | $49.57 | −$607.0K | −1.9%630.5K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Woods KeithChief Operating Officer | SSale | −10.2K | $49.57 | −$506.6K | −1.6%620.1K after | |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Peng KatieDirector | SSale | −5.45K | $53.88 | −$293.4K | −13.7%34.3K after | 3 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Reed JoshuaDirector | SSale | −3.05K | $53.74 | −$164.1K | −13.5%19.5K after | 2 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Burow KristinaDirector | SSale | −3.05K | $53.74 | −$164.1K | −2.6%114.7K after | 2 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Gilman MichaelDirector | SSale | −2.54K | $53.87 | −$137.1K | −4.1%59.5K after | 3 lots10b5-1 |
| Jul 6, 2026 (view filing)4:30 PM ET | Jul 1 | 5 days | Flier Jeffrey S.Director | SSale | −3.05K | $53.88 | −$164.5K | −9.9%27.9K after | 3 lots10b5-1 |